Related Experiment Video
Updated: Nov 17, 2025
12:21
MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
Published on: November 30, 2013
15.2K
MicroRNAs and Diabetes Mellitus Type 1
Farbod Bahreini1,2, Elham Rayzan3,4, Nima Rezaei2,3,5
1Department of Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.
Current Diabetes Reviews
|February 16, 2021
Summary
Early detection of type 1 diabetes is crucial. MicroRNA gene expression offers a promising, non-invasive biomarker for identifying this autoimmune disease and preventing organ damage.
Area of Science:
- Biochemistry
- Genetics
- Immunology
Background:
- Type 1 diabetes mellitus is a progressive autoimmune disease with genetic factors, potentially damaging organs like kidneys, eyes, and nerves.
- Early detection of type 1 diabetes is critical for preventing severe organ damage.
- MicroRNAs are key regulators of gene expression, and their altered expression is linked to various diseases, including type 1 diabetes.
Purpose of the Study:
- To review the dysregulation of microRNAs in type 1 diabetes.
- To explore the molecular mechanisms underlying microRNA involvement in pancreatic islet cell development and inflammation.
Main Methods:
- Literature review focusing on microRNA dysregulation in type 1 diabetes.
- Analysis of molecular mechanisms in pancreatic islet cell formation.
- Examination of inflammatory element and cytokine expression.
Main Results:
- Alterations in microRNA expression are reported in type 1 diabetes.
- MicroRNAs play a role in pancreatic islet cell development and inflammatory processes.
- Quantifying microRNA gene expression may serve as a non-invasive biomarker.
Conclusions:
- MicroRNA dysregulation is implicated in the pathogenesis of type 1 diabetes.
- MicroRNAs are involved in key molecular pathways affected in type 1 diabetes, including islet cell formation and inflammation.
- MicroRNA quantification presents a potential non-invasive diagnostic approach for early type 1 diabetes detection.
More Related Videos
Related Concept Videos
01:22Diabetes Mellitus: Overview and Type I Subtype
4.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.2K
01:22Diabetes Mellitus: Type 2 and Gestational
3.8K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.8K
01:20Pathophysiology of Diabetes
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.4K
01:22MicroRNAs
3.4K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.4K
01:22MicroRNAs
23.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.1K
01:15Diabetes: Symptoms, Diagnosis, and Complications
1.5K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.5K